title: Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
abstract: BACKGROUND
  Autoantibodies to the 20S proteasome represent an unspecific but common serological phenomenon in patients with systemic autoimmune diseases. Interestingly, a high prevalence of these antibodies have been observed in patients with connective tissue diseases, where anti-nuclear antibodies (ANAs) serve as an important diagnostic screening test.
  
  
  OBJECTIVE
  To disclose interference of anti-proteasome antibodies with known ANA patterns.
  
  
  METHODS
  Anti-proteasome antibodies were isolated for comprehensive immunofluorescence analyses. The immunofluorescence pattern of human anti-proteasome antibodies was compared with a panel of monoclonal and polyclonal reference antibodies, and colocalisation was analysed using confocal microscopy.
  
  
  RESULTS
  Anti-proteasome antibodies clearly contributed to the ANA patterns of their respective serum samples from patients with different rheumatic disorders. In addition to the nuclear pattern, proteasomal staining was also detectable in the cytoplasm, at the endoplasmic reticulum and perinuclear regions showing features overlapping with other known autoantibodies such as those to mitochondria. The specificity of anti-proteasome antibodies was proved by competition experiments and by colocalisation with monoclonal reference antibodies in confocal microscopy.
  
  
  CONCLUSIONS
  In ANA diagnostics, interference of anti-proteasome antibodies will have to be taken into account, especially in the differentiation of anti-cytoplasmatic autoantibodies.
authors.affiliation: Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin D-10117, Germany. eugen.feist@charite.de
authors.forename: E
authors.initials: E
authors.lastname: Feist
authors.forename: M
authors.initials: M
authors.lastname: Brychcy
authors.forename: G
authors.initials: G
authors.lastname: Hausdorf
authors.forename: B
authors.initials: B
authors.lastname: Hoyer
authors.forename: K
authors.initials: K
authors.lastname: Egerer
authors.forename: T
authors.initials: T
authors.lastname: Dörner
authors.forename: U
authors.initials: U
authors.lastname: Kuckelkorn
authors.forename: G-R
authors.initials: GR
authors.lastname: Burmester
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis / Q000276:immunology*; D000918:Antibody Specificity; D001323:Autoantibodies / Q000032:analysis / Q000276:immunology*; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000276:immunology; D001667:Binding, Competitive; D002277:Carcinoma / Q000276:immunology*; D045744:Cell Line, Tumor; D002850:Chromatography, Gel; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007822:Laryngeal Neoplasms / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000276:immunology; D008297:Male; D018613:Microscopy, Confocal; D008875:Middle Aged; D009220:Myositis / Q000175:diagnosis / Q000276:immunology; D046988:Proteasome Endopeptidase Complex / Q000276:immunology*; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000276:immunology
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D046988:Proteasome Endopeptidase Complex